Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Prucalopride in Chronic Constipation
NCT01116206Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- May 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of prucalopride in chronic constipation, sponsored by Johnson & Johnson. Started May 2010; status: completed.
02
Drugs
prucalopride
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT01116206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116206.